At present, Boyi Group owns Tiandirenhe, Boyi Bio, Hongmeng Bio, ACE and other brands. The company's main business layout is in three major business sectors: biological macromolecule purification, in vitro diagnostic reagent (IVD) core raw materials and life research reagents. Tiandirenhe will continue to focus on the application of microspheres in the biopharmaceutical industry and is committed to the localization of core biological reagents. Boyi Bio provides customers with key raw materials and overall solutions, and has established an advanced technology platform and innovative R&D system around diagnostic microspheres and other core raw materials in the in vitro diagnostic industry. Adhering to the vision of "making the production process of in vitro diagnostic test reagents more standardized and simpler", it is committed to the localization of core raw materials, breakthroughs and innovations, and creating more value for customers and partners. The ACE brand is oriented to the field of life science research, with the mission of "saving precious time for scientific researchers and boosting the rapid development of the biological industry". It focuses on the development and application of high-efficiency biological reagents and instruments, and is committed to optimizing conventional biological experimental processes, and providing high-efficiency, high-quality and cost-effective products for the majority of biological researchers.